The NG2-ITGA4 axis promotes leukemic aggressiveness in KMT2A-r B-ALL and can be targeted with natalizumab.
Acute Lymphoblastic Leukemia research
Moving in Blood, bioRxiv, Cell Reports, Gastroenterology, Journal of Experimental Botany, Nature Medicine and Nature Reviews Cancer.
- Moved, week to 22 Oct 2026
- 0
- Papers in 60 days
- 10
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Acute Lymphoblastic Leukemia research
Newest first · last 60 days
Venetoclax combined with pediatric-inspired chemotherapy achieves a 91% remission rate and improves survival in adolescents and adults with newly diagnosed Ph-negative ALL.
- Open access
- 1 cites
Ablating endothelial PERK enhances DLL4-NOTCH3 signaling, boosting lymphoid regeneration by 50% after irradiation in hematopoietic recovery.
- Open access
Inhibiting WNK1, an atypical kinase overexpressed in T-ALL, induces cell cycle arrest and disrupts mitosis, offering a promising therapeutic target with significant effects.
- Open access
Genomic and epigenomic profiling reveal over 40 molecular subtypes of acute lymphoblastic leukemia, enhancing classification and informing treatment strategies.
Browse JClub
Journals this month
- bioRxiv6117
- medRxiv1746
- PNAS447
- Sci Adv354
- JAMA268
- Environ Res246
- BMJ196
- Nat Commun173
- Environ Pollution167
- Nature151
- Science141
- Lancet128
- Cell Rep127
- NEJM118
- Plant Cell Environ114
- Applied & Environ Microbio112
- Curr Biol106
- Blood105
Topics moving, week to 22 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Cancer Immunotherapy and Biomarkers5
- Gut microbiota and health5
- Cancer Genomics and Diagnostics4
- Bacteriophages and microbial interactions4
- CAR-T cell therapy research3
- Lung Cancer Treatments and Mutations3
- Liver Disease Diagnosis and Treatment3
- Dementia and Cognitive Impairment Research3
